Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.

McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen SC, Norris KC, McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT; Kidney Early Evaluation Program Investigators.

Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45. doi: 10.1053/j.ajkd.2007.12.017.

PMID:
18359407
2.

Kidney Early Evaluation Program (KEEP). Findings from a community screening program.

McGill JB, Brown WW, Chen SC, Collins AJ, Gannon MR.

Diabetes Educ. 2004 Mar-Apr;30(2):196-8, 200-2, 206. Review.

PMID:
15095511
3.

Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP).

McCullough PA, Steigerwalt S, Tolia K, Chen SC, Li S, Norris KC, Whaley-Connell A; KEEP Investigators.

Curr Diab Rep. 2011 Feb;11(1):47-55. doi: 10.1007/s11892-010-0162-y. Review.

4.

Testing for chronic kidney disease: a position statement from the National Kidney Foundation.

Vassalotti JA, Stevens LA, Levey AS.

Am J Kidney Dis. 2007 Aug;50(2):169-80. Review.

PMID:
17660017
5.

Effect of pravastatin on cardiovascular events in people with chronic kidney disease.

Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M.

Circulation. 2004 Sep 21;110(12):1557-63. Epub 2004 Sep 13. Review.

6.

Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Kurella Tamura M, Wadley V, Yaffe K, McClure LA, Howard G, Go R, Allman RM, Warnock DG, McClellan W.

Am J Kidney Dis. 2008 Aug;52(2):227-34. doi: 10.1053/j.ajkd.2008.05.004. Epub 2008 Jun 30. Review.

7.

Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?

Moody WE, Edwards NC, Madhani M, Chue CD, Steeds RP, Ferro CJ, Townend JN.

Atherosclerosis. 2012 Jul;223(1):86-94. doi: 10.1016/j.atherosclerosis.2012.01.043. Epub 2012 Feb 2. Review.

PMID:
22349087
8.

[Algorithm of early detection and diagnosis of CKD].

Matsuo S, Yasuda Y, Maruyama S, Yuzawa Y.

Nihon Rinsho. 2008 Sep;66(9):1707-12. Review. Japanese.

PMID:
18788398
9.

New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.

Saab KR, Kendrick J, Yracheta JM, Lanaspa MA, Pollard M, Johnson RJ.

J Am Soc Nephrol. 2015 Feb;26(2):247-57. doi: 10.1681/ASN.2014040393. Epub 2014 Aug 4. Review.

10.

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimb├╝rger O, Massy Z.

Clin J Am Soc Nephrol. 2008 Mar;3(2):505-21. doi: 10.2215/CJN.03670807. Epub 2008 Jan 9. Review.

11.

The epidemics of cardiovascular disease in elderly patients with chronic kidney disease--two facets of the same problem.

Covic A, Gusbeth-Tatomir P, Goldsmith DJ.

Int Urol Nephrol. 2006;38(2):371-9. Review.

PMID:
16868714
12.

The burden of hypertension and kidney disease in Northeast India: the Institute for Indian Mother and Child noncommunicable diseases project.

Gallieni M, Aiello A, Tucci B, Sala V, Brahmochary Mandal SK, Doneda A, Genovesi S.

ScientificWorldJournal. 2014 Jan 27;2014:320869. doi: 10.1155/2014/320869. eCollection 2014. Review.

13.

Obesity and kidney disease: Hidden consequences of the epidemic.

Kovesdy CP, Furth S, Zoccali C; World Kidney Day Steering Committee.

Physiol Int. 2017 Mar 1;104(1):1-14. doi: 10.1556/2060.104.2017.1.9. Review.

PMID:
28361575
14.

Supplemental Content

Support Center